Replies to post #22538 on Cannabis Science Inc (fka CBIS)

[DouglasJH]

Yes, this stock is trading on future success. The chief complaint in scientific circles is that cannabis, in raw form, lacks standardization. CBIS's ability to provide a standardized blend of whole cannabis, in a patented delivery method, targeting specific diseases could be worth hundreds of millions of dollars.

Okay, so that's the principle reason there are many longs. Not just a hope dream, but a real cure or easement for hard to treat diseases. The longs take the ups and the downs, while some flip for more shares.

It is obvious that none of you have any idea about what is going on with the company......please give me some facts and evidence about CBIS ...

Here is the current numbers before Friday's new numbers.

Per Share Data CBIS
EPS excluding extraordinary items (TTM) -0.19
EPS Normalized (MRFY) -0.15
Rev per share (TTM) 0.00
BV per share (MRQ) -0.01
Tangible BV per share (MRQ) -0.01
Cash per share (MRQ) 0.0000
Cash flow per share (TTM) -0.15
Indicated Annual Dividend (US) 0.00